Search

Your search keyword '"Morrow, David A."' showing total 182 results
Start Over Author "Morrow, David A." Region united states
182 results on '"Morrow, David A."'

9. Whoppers & floppers.

Author

Morrow, David J. and Alexander, Kelly

Subjects
FAST food restaurants, CONVENIENCE foods
Abstract

Presents a recap of the biggest hits and misses in the fast food industry in the United States in the 20th century including recipes served from some of these notable fast food restaurants. First fast food hit in the form of the White Castle burger; Failures from the lower-fat food offerings; Forecasts for the industry.

Published
1996

10. The coast is clear with NOAA.

Author

Morrow, David

Subjects
SHORE protection, COASTAL zone management
Abstract

Reports on the efforts of the US National Oceanic and Atmospheric Administration (NOAA) to manage and preserve the American coastline. Operation of estuary reserves and marine sanctuaries; Offer of opportunities for students and volunteers to help through the Great American Fish Count; Information network of the organization.

Published
1998

11. History detectives at Little Bighorn.

Author

Morrow, David

Subjects
ARCHAEOLOGICAL surveying, LITTLE Bighorn, Battle of the, Mont., 1876
Abstract

Explains how National Park Service officials, archaeologists and historical scientists investigated what actually happened in the Battle of the Little Bighorn in Montana. Wildfire on the site in 1983 as a precursor to the archaeological study; Division of the battlefield into grids to search for artifacts; Conclusions about the weapons carried by American Indians and United States Army soldiers in 1876.

Published
1997

13. Bombardier subsidy dispute intensifies.

Author

MORROW, DAVID KAMINSKI

Subjects
IMPORTS
Abstract

The article focuses on the impact of trade dispute between organizations Boeing and Bombardier on the diplomatic relations between Canada, Great Britain and the U.S., and talks of increase of import duty on CSeries aircraft CS100, and investigation by the U.S. International Trade Commission.

Published
2017

14. Civil aircraft sales to Iran Air threatened by US legislators.

Author

KAMINSKI-MORROW, DAVID

Subjects
LEGISLATIVE bills, IRAN-United States relations, AIRLINE industry
Abstract

The article reports on the passage of a bill introduced by Republican Representative Bill Huizenga of Michigan, by U.S. legislators on November 17, 2016 that would block U.S. financing of commercial aircraft sales to Iranian carriers. Topics discussed include agreements negotiated by Airbus and Boeing after the lifting of nuclear-related sanctions on Iran and assurance given by Huizenga to U.S. citizens that their savings will not go to Iran Air and national security will not be undermined.

Published
2016

15. Investigators split over Delta mishap.

Author

KAMINSKI-MORROW, DAVID

Subjects
AIRCRAFT accident investigation, AIRPLANE tires
Abstract

The article focuses on the investigation by Spanish and U.S. authorities on the cause of a tyre burst which substantially damaged a Delta Air Lines Boeing 767-300ER during take-off at Madrid Barajas for New York. Topics covered include the rejection by the U.S. team of the Spanish theory that metal fragment which left inside the tyre during retreading in July 2013 caused the damage, and the belief by U.S. investigators that the fragment was present on the runway.

Published
2016

16. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Author

Gulati, Martha MS, FACC, Chair, Levy, Phillip D. FACC, Vice Chair, Mukherjee, Debabrata MS, FACC, Vice Chair, Amsterdam, Ezra FACC, Bhatt, Deepak L. FACC, FAHA, Birtcher, Kim K. MS, PharmD, AACC, Blankstein, Ron FACC, MSCCT, Boyd, Jack, Bullock-Palmer, Renee P. FACC, FASE, FSCCT, Conejo, Theresa N, FAHA, Diercks, Deborah B. FACC, Gentile, Federico FACC, Greenwood, John P. FSCMR, FACC, Hess, Erik P., Hollenberg, Steven M. FACC, FCCP, Jaber, Wael A. FACC, FASE, Jneid, Hani FACC, FAHA, Joglar, Jose A. FACC, Morrow, David A. FACC, FAHA, and O'Connor, Robert E. FAHA

Subjects
*CHEST pain diagnosis, *CHEST pain treatment, *CLINICAL trials, *ACQUISITION of data, *MEDICAL protocols, *CHEST pain, *ALGORITHMS
Abstract

Aim: This executive summary of the clinical practice guideline for the evaluation and diagnosis of chest pain provides recommendations and algorithms for clinicians to assess and diagnose chest pain in adult patients.Methods: A comprehensive literature search was conducted from November 11, 2017, to May 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Additional relevant studies, published through April 2021, were also considered. Structure: Chest pain is a frequent cause for emergency department visits in the United States. The "2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain" provides recommendations based on contemporary evidence on the assessment and evaluation of chest pain. These guidelines present an evidence-based approach to risk stratification and the diagnostic workup for the evaluation of chest pain. Cost-value considerations in diagnostic testing have been incorporated and shared decision-making with patients is recommended. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

17. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Author

Gulati, Martha MS, FACC, Chair, Levy, Phillip D. FACC, Vice Chair, Mukherjee, Debabrata MS, FACC, Vice Chair, Amsterdam, Ezra FACC, Bhatt, Deepak L. FACC, FAHA, Birtcher, Kim K. MS, PharmD, AACC, Blankstein, Ron FACC, MSCCT, Boyd, Jack, Bullock-Palmer, Renee P. FACC, FASE, FSCCT, Conejo, Theresa N, FAHA, Diercks, Deborah B. FACC, Gentile, Federico FACC, Greenwood, John P. FSCMR, FACC, Hess, Erik P., Hollenberg, Steven M. FACC, FCCP, Jaber, Wael A. FACC, FASE, Jneid, Hani FACC, FAHA, Joglar, Jose A. FACC, Morrow, David A. FACC, FAHA, and O'Connor, Robert E. FAHA

Subjects
*CHEST pain diagnosis, *CHEST pain treatment, *CLINICAL trials, *ACQUISITION of data, *CHEST pain, *ALGORITHMS
Abstract

Aim: This clinical practice guideline for the evaluation and diagnosis of chest pain provides recommendations and algorithms for clinicians to assess and diagnose chest pain in adult patients.Methods: A comprehensive literature search was conducted from November 11, 2017, to May 1, 2020, encompassing randomized and nonrandomized trials, observational studies, registries, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Additional relevant studies, published through April 2021, were also considered. Structure: Chest pain is a frequent cause for emergency department visits in the United States. The "2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain" provides recommendations based on contemporary evidence on the assessment and evaluation of chest pain. This guideline presents an evidence-based approach to risk stratification and the diagnostic workup for the evaluation of chest pain. Cost-value considerations in diagnostic testing have been incorporated, and shared decision-making with patients is recommended. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

18. No Direct Talks Set by 2 Sides In Boeing Strike.

Author

Morrow, David J.

Subjects
*AIRCRAFT industry strikes & lockouts, *AIRCRAFT industry workers, *LABOR unions, *AEROSPACE engineers, *EMPLOYEES
Abstract

Reports on the situation between the Boeing Company and its striking engineers and technical workers in the United States. How each group will meet separately with federal mediators amid escalating tensions between the two; Details on the strike and the demands of the workers; Outlook for compromise between the groups.

Published
2000

19. Twilight of Turboprops?

Author

Morrow, David J.

Subjects
*TURBOPROP transports, *TRANSPORT planes, *JET planes, *COMMERCIAL aeronautics
Abstract

Focuses on the possible decline of commercial turboprop airplanes in the United States, as airlines seek to replace them with jet airplanes. Reasons why passengers prefer jets to turboprops; Increased competition among airlines which has led to this situation; Example of Continental Airlines. Delta Air Lines, and Northwest Airlines; Jet makers Embraer and Bombardier; Outlook for the situation.

Published
2000

20. In-flight cargo shift damaged Alaskan DC-6 freighter.

Author

KAMINSKI-MORROW, DAVID

Subjects
AIRCRAFT accident investigation
Abstract

The article reports that a U.S. National Transportation Safety Board (NTSB) investigation into the emergency landing of a Douglas DC-6 airplane operated by Everts Air Cargo on November 25, 2013, in Alaska found structural damage was caused by shifting cargo.

Published
2014

21. Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19: Findings From the American Heart Association's COVID-19 Cardiovascular Disease Registry.

Author

Rodriguez, Fatima, Solomon, Nicole, de Lemos, James A., Das, Sandeep R., Morrow, David A., Bradley, Steven M., Elkind, Mitchell S. V., Williams IV, Joseph H., Holmes, DaJuanicia, Matsouaka, Roland A., Gupta, Divya, Gluckman, Ty J., Abdalla, Marwah, Albert, Michelle A., Yancy, Clyde W., Wang, Tracy Y., and Williams, Joseph H

Subjects
*CARDIOVASCULAR diseases, *COVID-19, *CARDIOGENIC shock, *MEDICAL registries, *ETHNIC differences, *RACIAL differences, *RESEARCH funding
Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic has exposed longstanding racial and ethnic inequities in health risks and outcomes in the United States. We aimed to identify racial and ethnic differences in presentation and outcomes for patients hospitalized with COVID-19.Methods: The American Heart Association COVID-19 Cardiovascular Disease Registry is a retrospective observational registry capturing consecutive patients hospitalized with COVID-19. We present data on the first 7868 patients by race/ethnicity treated at 88 hospitals across the United States between January 17, 2020, and July 22, 2020. The primary outcome was in-hospital mortality. Secondary outcomes included major adverse cardiovascular events (death, myocardial infarction, stroke, heart failure) and COVID-19 cardiorespiratory ordinal severity score (worst to best: death, cardiac arrest, mechanical ventilation with mechanical circulatory support, mechanical ventilation with vasopressors/inotrope support, mechanical ventilation without hemodynamic support, and hospitalization alone. Multivariable logistic regression analyses were performed to assess the relationship between race/ethnicity and each outcome adjusting for differences in sociodemographic, clinical, and presentation features, and accounting for clustering by hospital.Results: Among 7868 patients hospitalized with COVID-19, 33.0% were Hispanic, 25.5% were non-Hispanic Black, 6.3% were Asian, and 35.2% were non-Hispanic White. Hispanic and Black patients were younger than non-Hispanic White and Asian patients and were more likely to be uninsured. Black patients had the highest prevalence of obesity, hypertension, and diabetes. Black patients also had the highest rates of mechanical ventilation (23.2%) and renal replacement therapy (6.6%) but the lowest rates of remdesivir use (6.1%). Overall mortality was 18.4% with 53% of all deaths occurring in Black and Hispanic patients. The adjusted odds ratios for mortality were 0.93 (95% CI, 0.76-1.14) for Black patients, 0.90 (95% CI, 0.73-1.11) for Hispanic patients, and 1.31 (95% CI, 0.96-1.80) for Asian patients compared with non-Hispanic White patients. The median odds ratio across hospitals was 1.99 (95% CI, 1.74-2.48). Results were similar for major adverse cardiovascular events. Asian patients had the highest COVID-19 cardiorespiratory severity at presentation (adjusted odds ratio, 1.48 [95% CI, 1.16-1.90]).Conclusions: Although in-hospital mortality and major adverse cardiovascular events did not differ by race/ethnicity after adjustment, Black and Hispanic patients bore a greater burden of mortality and morbidity because of their disproportionate representation among COVID-19 hospitalizations. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

22. UPS A300 crash flags risky approach.

Author

KAMINSKI-MORROW, DAVID and Hemmerdinger, Jon

Subjects
AIRCRAFT accident investigation, AIRBUS A300, AIR speed, AERONAUTICAL safety measures, COCKPIT warning systems, AERONAUTICS
Abstract

The article focuses on the investigation on the crash accident involving the UPS Airbus A300-600 freighter. Topics discussed include the risky approach taken by the twinjet, the expected approach airspeed of the aircraft and the results of the assessment on ground-proximity warning system and flight control inputs. Also included are the insights of the U.S. Aviation Safety Reporting System on the issue.

Published
2013

23. Boeing eyes 'perfect' return for 787s.

Author

KAMINSKI-MORROW, DAVID and Flightglobal staff

Subjects
BOEING 787 Dreamliner (Jet transport), AIRWORTHINESS certificates
Abstract

The article discusses airline carrier Ethiopian Airlines and its decision to return its Boeing Co.-manufactured 787 Dreamliner aircrafts back into service following the release of an airworthiness directive from the U.S. Federal Aviation Administration (FAA) on April 26, 2013. Other airline carriers which use 787s are also mentioned, including Qatar Airways, the Polish carrier LOT, and Japan Airlines.

Published
2013

24. A Movable Epidemic.

Author

Morrow, David J.

Subjects
*PHARMACEUTICAL industry, *AIDS patients, *DRUG marketing, *MEDICAL advertising
Abstract

Discusses United States drug companies marketing of AIDS drugs in the face of the changing profile of those who have the disease. Grants funded by Glaxo Wellcome PLC in 1999; Value of the worldwide market for AIDS drugs; Demographic and sales statistics; Marketing by Merck, Bristol-Myers Squibb, Glaxo Wellcome and DuPont Pharmaceuticals.

Published
1999

25. Maker of Norplant Offers a Settlement In Suit Over Effects.

Author

Morrow, David J.

Subjects
*NORGESTREL, *CLASS actions, *CONTRACEPTIVES, *DRUG side effects, *ACTIONS & defenses (Law)
Abstract

Reports that the American Home Products Corp. has agreed in August of 1999 to offer cash settlements to the group of women who contend that they were not adequately warned about the possible side effects of the company's Norplant contraceptive. How offering any settlement is a change of strategy for the company; Comments from lawyer Turner W. Branch over their disappointment at the size of the offers; Description of the contraceptive and the side effects the women experienced.

Published
1999

26. Abbott Plans To Buy Alza In Stock Swap.

Author

Morrow, David J.

Subjects
*PURCHASING of business enterprises, *STOCKS (Finance), *PHARMACEUTICAL industry mergers
Abstract

Reports the June 21, 1999 announcement by Abbott Laboratories of plans to acquire Alza Corporation. Value and terms of the stock swap deal; Implications for the United States pharmaceutical industry; Praise for Abbott chairman and chief executive Miles D. White; Impact on Abbott and Alza shares; Analysis of the deal.

Published
1999

27. Carolina Bank Robberies Show That Friendliness Carries a Price.

Author

Morrow, David J.

Subjects
*BANK robberies, *CRIME statistics, *BANK security, *THIEVES, *BANKERS, *ATTITUDE (Psychology)
Abstract

Discusses bank robbery in North Carolina as of spring 1999. Statistics for 1998 and comparison to United States statistics; Bank executives' attitude toward robberies and the robbery trend; Profile of bank robbers; Apprehension of perpetrators; Bank and personnel security measures.

Published
1999

28. New Profits in Old Bottles.

Author

Morrow, David J.

Subjects
*CLINICAL pharmacology, *PHARMACEUTICAL industry & economics, *DRUG utilization, *ECONOMICS, DRUGS & economics
Abstract

Focuses on the pharmaceutical company practice of developing multiple uses for existing compounds. Glaxo Wellcome PLC's marketing of bupropion hydrochloride as Wellbutrin, a treatment for depression, and as Zyban, an aid to smoking cessation; Impact on the trend of changes in United States Food and Drug Administration policies; Economic advantages of developing further indications for existing drugs.

Published
1999

29. Lilly to Stop Developing Migraine Drug.

Author

Morrow, David J.

Subjects
*EXPERIMENTAL pharmacology, *HEADACHE treatment, *MIGRAINE
Abstract

Reports an announcement by Eli Lilly & Company that it would end development of an experimental migraine drug that had been billed as a promising method to treat headaches. Response of analysts; Competitive nature of the market for migraine drugs in the United States; Stock statistics of the company; Impact of the announcement on the stocks of the Synaptic Pharmaceutical Corporation, which was developing the drug with Lilly.

Published
1999

30. DuPont Having Discussions With Pioneer.

Author

Morrow, David J.

Subjects
*AGRICULTURAL industries, *MERGERS & acquisitions
Abstract

Reports the March 12, 1999 announcement that Pioneer Hi-Bred International and the DuPont Company are discussing a possible combination. Analysts' interpretation of the announcement; Possibility of a United States agriculture industry bidding war for Pioneer; Pioneer share price response; DuPont's stake in partnership projects and previous agreement with Pioneer.

Published
1999

31. Vision Things.

Author

Morrow, David J.

Subjects
*INTRAOCULAR lenses, *MYOPIA treatment, *ARTIFICIAL implants, TREATMENT of vision disorders
Abstract

Discusses implantation of polymer arcs as an experimental treatment for myopia. Description of the procedure; California-based Keravision's production of the arcs, known as Intacs; Time frame for the expected United States Food and Drug Administration approval of Intacs; Competitors, and other products under development; US market for vision correction products; Risks of implants.

Published
1999

32. Struggling to Spell R-E-L-I-E-F.

Author

Morrow, David J.

Subjects
*MIGRAINE, *PHARMACEUTICAL industry, *DRUG marketing, *HEADACHE treatment
Abstract

Looks at hurdles to United States sales of prescription drugs for the treatment of migraine headaches. Characteristics of migraines; Effectiveness of drugs known as triptans; Drugs made by Glaxo Wellcome, Merck & Company and Zeneca Pharmaceuticals; Estimate of the size of the market; Sales statistics and comparison to expectations; Marketing of the drugs.

Published
1998

33. A Medicine Chest or a Grocery Shelf?

Author

Morrow, David J.

Subjects
*FUNCTIONAL foods, *FOOD, *NUTRITION, *HEALTH
Abstract

Focuses on so-called functional foods and claims made for their effectiveness in combating heart disease, osteoporosis, cholesterol and other conditions. Criticism of exaggerated claims; Prices; Profitability, and estimated United States sales in 1999; US Food and Drug Administration criteria for functional foods; Marketing the products; Novartis' introduction of its Aviva brand; Johnson & Johnson's marketing of Benecol; Mead Johnson's snack products.

Published
1999

34. Fen-Phen Maker to Pay Billions In Settlement of Diet-Injury Cases.

Author

Morrow, David J.

Subjects
*FENFLURAMINE, *APPETITE depressants, *PRODUCT liability of drugs, *PRODUCT safety, *CASE studies, *DRUG side effects, *ACTIONS & defenses (Law)
Abstract

Reports American Home Products' October 7, 1999 agreement to a settlement with people who claim injury from use of the diet pill combination fen-phen. Size of the settlement, number of people involved, and conditions; Response of executives and pharmaceutical industry analysts; Implications for further liability; United States use of the drug; History of litigation.

Published
1999

35. Highflying Generic Drug Stocks Now Sharply Lower.

Author

Morrow, David J.

Subjects
*GENERIC drugs, *PHARMACEUTICAL industry, *STOCKS (Finance)
Abstract

Reports on the stocks performance of generic drug companies in the United States (US). Stocks posted by Watson Pharmaceuticals firm and Forest Laboratories company; Lawsuit filed by the US Federal Trade Commission against Hoechst Marion Roussel company and Andrx company; Expectation on the investigation initiative of the government.

Published
1999

36. The Great American Drug Stock Selloff.

Author

Morrow, David J.

Subjects
*STOCKS (Finance), *PHARMACEUTICAL industry
Abstract

Focuses on the performance of drug stocks in 1998 and 1999 in the United States. Factors attributed to the negative return of drug stocks in 1999; When the decline in the overall market will continue; Financial status of drug companies; Implications.

Published
1999

37. Drug Makers Reporting Mixed Results During Second Quarter.

Author

Morrow, David J.

Subjects
*PHARMACEUTICAL industry, *CORPORATE profits
Abstract

Discusses the profit increase of pharmaceutical companies in the United States for the second quarter of 1999. Johnson & Johnson; SmithKline Beecham; American Home Products; Bristol-Myers Squibb Co.

Published
1999

38. Women's Drugs: Big in Profits, Narrow in Scope.

Author

Morrow, David J.

Subjects
*WOMEN'S health, *PHARMACEUTICAL industry
Abstract

Discusses the relationship between women's health and pharmaceutical companies. Problem with pharmaceuticals in selling their products; Information on different drug companies in the United States with regards to spending on women's initiatives; Necessity for having a separate division for women's health.

Published
1999

39. Corporate Park's Bucolic Appeal Is Lost in Traffic.

Author

Morrow, David J.

Subjects
*TRAFFIC congestion, *INDUSTRIAL districts
Abstract

Reports on the traffic problems at Research Triangle Park in North Carolina. Background information on the corporate park; Comments on the issue; Population growth in the counties surrounding the park.

Published
1999

40. Strong Earnings Lift Pharmaceutical Stocks.

Author

Morrow, David J.

Subjects
*STOCKS (Finance)
Abstract

Reports on the increase in pharmaceutical stocks on April 20, 1999 in the United States. Reasons for the increase; First-quarter net income of the Schering-Plough Corp.; Earnings posted by Johnson & Johnson; Net earnings of American Home Products; Recommendation for approval of drug from Merck & Company.

Published
1999

41. Genentech Drops Nerve Drug For Diabetics After Tests Fail.

Author

Morrow, David J.

Subjects
*CLINICAL drug trials, *TREATMENT of diabetes, *GOVERNMENT policy
Abstract

Reports on the failure of the clinical tests for the drug Neuleze manufactured by Genentech Inc. to promote nerve growth in diabetic patients. Settlement cost for illegal marketing of these drugs; Implication of the case.

Published
1999

42. Five Perspectives on the Business of Reshaping Medicare.

Author

Freudenheim, Milt and Morrow, David J.

Subjects
*MEDICARE, *PRESSURE groups
Abstract

Discusses how various interest groups view the kind of changes to Medicare that the commission is considering in the United States. Reason for restructuring Medicare; Expectation of for-profit hospitals; Expectation of doctors; View of health plan operators.

Published
1999

43. Market Place.

Author

Morrow, David J.

Subjects
*PHARMACEUTICAL industry, *STOCKS (Finance)
Abstract

Looks at the performance of stocks of several pharmaceutical companies in the United States in 1998 and January 1999. Negative returns posted by Warner-Lambert and Pfizer; Drug index of Standard & Poor's; Profitable drugs from Eli Lilly and Warner-Lambert.

Published
1999

44. Collectors Are Going Hollywood.

Author

Morrow, David J.

Subjects
*COLLECTIBLES, *AMERICAN business enterprises, *CELEBRITIES
Abstract

Reports that the collection of Hollywood memorabilia has become a lucrative business mainstream in the United States. Information on Perry Kinney's collection; Factors that contributed to the collection boom; Influence of electronic commerce in the collection business.

Published
1999

45. American Home to Settle Some 1,400 Fen-Phen Suits.

Author

Morrow, David J.

Subjects
*LEGAL settlement, *FENFLURAMINE, *DRUG side effects, *ACTIONS & defenses (Law)
Abstract

Reports that American Home Products Corp. has agreed to settle the injury cases filed in Mississippi over its diet drug combination fen-phen. Implication of the lawsuits to the company's merger plans with Warner-Lambert company; Reaction from market analysts; Background of the lawsuits.

Published
1999

46. Health Care Consumers Can Expect Change, and a Shock or Two.

Author

Morrow, David J.

Subjects
*MEDICAL care, *GENOMES, *DRUG utilization
Abstract

Presents an outlook for the medical care system of the United States. Significant change in the health care system; Issues on medications; Benefit of breakthroughs in genomic technology.

Published
1999

47. Abbott Drops Plan to Buy Alza, Blaming F.T.C. Antitrust Concern.

Author

Morrow, David J.

Subjects
*PHARMACEUTICAL industry mergers
Abstract

Reports on the decision of Abbott Laboratories to abandon its plan to acquire Alza Corp., because of antitrust opposition from the United States Federal Trade Commission. Issue on the planned marketing of the prostate cancer drug manufactured by Alza; Settlement of complaints against the standard of Abbott's medical test kits; Concerns expressed by the commission.

Published
1999

48. Drug Maker To Close Plants And Cut Jobs.

Author

Morrow, David J.

Subjects
*PHARMACEUTICAL industry personnel, *EARNINGS per share, *STOCK prices, *CHARGEBACKS, *DISMISSAL of employees, *FORECASTING
Abstract

Reports the December 3, 1998 announcement by United States drugmaker Johnson & Johnson of its plan to close plants and cut jobs. Amount of the fourth-quarter charge that it will take; Extent of the cuts globally and in the US; Factors in the move; Industry analysts' response; Share price response; Earnings forecast.

Published
1998

49. Control split preceded close conflict.

Author

KAMINSKI-MORROW, DAVID

Subjects
NEAR misses (Aeronautics), AIRPLANE collision avoidance, AIR traffic control accidents
Abstract

The article reports that a U.S. investigation by the National Transportation Safety Board has attributed a near miss between a Boeing 777 jet transport operated by American Airlines and two U.S. Air Force transport planes to confusion among air traffic controllers. The near miss occurred on January 21, 2011 in airspace off the coast of New York City INSET: Inactive transponder hid departing 757 from Atlanta radar.

Published
2012

50. Speedbrakes missed before 737 slip.

Author

KAMINSKI-MORROW, DAVID

Subjects
AIRCRAFT accident investigation, HUMAN factors in aircraft accidents, BOEING 737 (Jet transport), ACCIDENTS
Abstract

The article reports that the U.S. National Transportation Safety Board (NTSB) has determined that the speedbrakes of a Boeing 737 jet transport operated by Southwest Airlines were not armed before the plane slid off the runway of Midway Airport in Chicago, Illinois while landing. This was attributed to a mistake made by the flight crew during the landing.

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results